0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Monoamine Oxidase – Drugs In Development, 2024

    The Monoamine Oxidase pipeline drugs market research report outlays comprehensive information on the Monoamine Oxidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Infectious Disease, Oncology, and Immunology which include indications of Parkinson's Disease, Alzheimer's Disease, Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Coronavirus Disease 2019 (COVID-19) Pneumonia, Glioma, and Autoimmune Disorders. It...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Ceramide Glucosyltransferase – Drugs In Development, 2024

    The Ceramide Glucosyltransferase pipeline drugs market research report outlays comprehensive information on the Ceramide Glucosyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Genetic Disorders, Central Nervous System, and Oncology which include indications of Fabry Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), Tay-Sachs Disease, Polycystic Kidney Disease, Parkinson's Disease, Neuropathy, Solid Tumor, and Bile Duct Cancer (Cholangiocarcinoma)...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Mucolipin 1 – Drugs In Development, 2024

    The Mucolipin 1 pipeline drugs market research report outlays comprehensive information on the Mucolipin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, Undisclosed, and Musculoskeletal Disorders which include indications of Neurodegenerative Diseases, Parkinson's Disease, Lysosomal Storage Disorder, Niemann-Pick Disease Type C, Unspecified Rare Disease, and Muscular Dystrophy. It also reviews key...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Casein Kinase 2 – Drugs In Development, 2024

    The Casein Kinase 2 pipeline drugs market research report outlays comprehensive information on the Casein Kinase 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, and Infectious Disease which include indications of Lung Cancer, Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Huntington Disease, Neurodegenerative Diseases, Coronavirus Disease 2019 (COVID-19), and Community Acquired Pneumonia....

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Phosphodiesterase 9 – Drugs In Development, 2024

    The Phosphodiesterase 9 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 9 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Hematological Disorders, and Undisclosed which include indications of Congestive Heart Failure (Heart Failure), Systolic Heart Failure, Alzheimer's Disease, Parkinson's Disease, Sickle Cell Disease, Thalassemia, and Unspecified Rare Disease. It also...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Protein O GlcNAcase – Drugs In Development, 2024

    The Protein O GlcNAcase pipeline drugs market research report outlays comprehensive information on the Protein O GlcNAcase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Metabolic Disorders, and Genetic Disorders which include indications of Alzheimer's Disease, Parkinson's Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), and Tay-Sachs Disease. It also reviews key players involved in Protein O...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Cytochrome b 245 Heavy Chain – Drugs In Development, 2024

    The Cytochrome b 245 Heavy Chain pipeline drugs market research report outlays comprehensive information on the Cytochrome b 245 Heavy Chain targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Genetic Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Chronic Granulomatous Disease, Cardiovascular Disease, Pulmonary Hypertension, Alzheimer's Disease, Epilepsy, and Influenzavirus A Infections. It...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Cholesteryl Ester Transfer Protein – Drugs In Development, 2024

    The Cholesteryl Ester Transfer Protein pipeline drugs market research report outlays comprehensive information on the Cholesteryl Ester Transfer Protein targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, Central Nervous System, and Infectious Disease which include indications of Dyslipidemia, Heterozygous familial hypercholesterolemia (heFH), Cardiovascular, Cardiovascular Disease, Alzheimer's Disease, and Coronavirus Disease 2019 (COVID-19). It also...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Glucosylceramidase – Drugs In Development, 2024

    The Glucosylceramidase pipeline drugs market research report outlays comprehensive information on the Glucosylceramidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Gaucher Disease, Gaucher Disease Type I, Parkinson's Disease, and Lewy Body Dementia. It also reviews key players involved in Glucosylceramidase targeted therapeutics development with respective active...

  • Product Insights

    New
    $3,500 | June 2024
    Product Insights
    New

    Alpha Glucosidase – Drugs In Development, 2024

    The Alpha Glucosidase pipeline drugs market research report outlays comprehensive information on the Alpha Glucosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Central Nervous System which include indications of Pompe Disease, and Lafora Disease (Unverricht Disease). It also reviews key players involved in Alpha Glucosidase targeted therapeutics development with respective active and dormant...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.